Pacala Mark L 4
4 · Oncology Institute, Inc. · Filed Nov 24, 2025
Insider Transaction Report
Form 4
Pacala Mark L
Director
Transactions
- Award
Common Stock
2025-11-20+46,296→ 221,267 total - Award
Common Stock
2025-11-20+35,494→ 256,761 total
Footnotes (2)
- [F1]Represents restricted stock units that vest in full on Issuer's 2026 annual stockholder meeting date, subject to continued service with the Issuer through such vesting date.
- [F2]Represents restricted stock units that were fully vested upon grant.